These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12681418)

  • 1. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication.
    Saba S; Atiga WL; Barrington W; Ganz LI; Kormos RL; MacGowan GA; Mathier MA; McNamara DM; Obioha-Ngwu O; Murali S
    J Heart Lung Transplant; 2003 Apr; 22(4):411-8. PubMed ID: 12681418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.
    Pappone C; Vicedomini G; Augello G; Mazzone P; Nardi S; Rosanio S
    Am J Cardiol; 2003 May; 91(9A):74F-80F. PubMed ID: 12729853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.
    Fonarow GC; Feliciano Z; Boyle NG; Knight L; Woo MA; Moriguchi JD; Laks H; Wiener I
    Am J Cardiol; 2000 Apr; 85(8):981-5. PubMed ID: 10760339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK
    J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation.
    El-Assaad I; Al-Kindi SG; Oliveira GH; Boyle GJ; Aziz PF
    Heart Rhythm; 2015 Dec; 12(12):2443-8. PubMed ID: 26247317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
    Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A
    Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary preventive cardioverter-defibrillator implantation (Pro-ICD) in patients awaiting heart transplantation. A prospective, randomized, controlled 12-year follow-up study.
    Pezawas T; Grimm M; Ristl R; Kivaranovic D; Moser FT; Laufer G; Schmidinger H
    Transpl Int; 2015 Jan; 28(1):34-41. PubMed ID: 25176271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.